Connect Biopharma Holdings Limited

NasdaqGM:CNTB Stock Report

Market Cap: US$55.3m

Connect Biopharma Holdings Balance Sheet Health

Financial Health criteria checks 6/6

Connect Biopharma Holdings has a total shareholder equity of $110.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $120.6M and $10.1M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$110.24m
EquityUS$110.48m
Total liabilitiesUS$10.09m
Total assetsUS$120.57m

Recent financial health updates

Recent updates

Connect Biopharma Holdings (NASDAQ:CNTB) Is In A Strong Position To Grow Its Business

Sep 27
Connect Biopharma Holdings (NASDAQ:CNTB) Is In A Strong Position To Grow Its Business

Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Are In A Position To Invest In Growth

Mar 07
Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Are In A Position To Invest In Growth

Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?

Sep 19
Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?

Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Mar 29
Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Deliver On Growth Plans?

Dec 14
Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Deliver On Growth Plans?

Market Appears To Relegate Connect Biopharma To A Long-Term Hold

Oct 10

Connect Biopharma Is A Sleeper Heading Into October Data Readout

Sep 26

Connect Biopharma reports 1H results

Sep 13

We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Aug 12
We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Apr 29
We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Connect Biopharma's Latest Dermatitis Drug Update Fails To Pump Up Shares

Jan 12

We're Hopeful That Connect Biopharma Holdings (NASDAQ:CNTB) Will Use Its Cash Wisely

Jan 01
We're Hopeful That Connect Biopharma Holdings (NASDAQ:CNTB) Will Use Its Cash Wisely

Financial Position Analysis

Short Term Liabilities: CNTB's short term assets ($115.9M) exceed its short term liabilities ($9.6M).

Long Term Liabilities: CNTB's short term assets ($115.9M) exceed its long term liabilities ($467.0K).


Debt to Equity History and Analysis

Debt Level: CNTB is debt free.

Reducing Debt: CNTB currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CNTB has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: CNTB has sufficient cash runway for 2.3 years if free cash flow continues to reduce at historical rates of 12.9% each year.


Discover healthy companies